Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "industry"

1754 News Found

Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Sun Pharma to acquire Organon in $11.75 billion all-cash deal
News | April 27, 2026

Sun Pharma to acquire Organon in $11.75 billion all-cash deal

Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally


Mandeep Singh Kumar, Shankha Banerjee  join NATHEALTH leadership team
Healthcare | April 27, 2026

Mandeep Singh Kumar, Shankha Banerjee join NATHEALTH leadership team

New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement


Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments
Healthcare | April 27, 2026

Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments

New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security


NIT Rourkela secures patent for rapid spice adulteration detection system
News | April 27, 2026

NIT Rourkela secures patent for rapid spice adulteration detection system

FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants


Raay Neo Pharma launches operations to expand access to quality healthcare across India
News | April 27, 2026

Raay Neo Pharma launches operations to expand access to quality healthcare across India

Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies


Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences
People | April 27, 2026

Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences

Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role


NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research
Policy | April 25, 2026

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research

As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.


Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1
News | April 25, 2026

Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1

The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network


Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade,  Head Bioprocessing, India, Avantor
interviews | April 24, 2026

Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Head Bioprocessing, India, Avantor

Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region